GASTROINTESTINAL MICROBLEEDING AFTER ASPIRIN AND NAPROXEN.LUSSIER A; ARSENAULT A; VARADY J et al.1978; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1978; VOL. 23; NO 4; PP. 402-407; BIBL. 13 REF.Article

TAUX D'UREE DANS LE SANG ET D'AMMONIAQUE DANS LE RUMEN DURANT LE REPAS ET LE JEUNE DE MOUTONS RECEVANT DIVERS REGIMES ALIMENTAIRESSZANYIOVA M; BAJO M; VARADY J et al.1972; ZIVOC. VYROBA; CESKOSL.; DA. 1972; VOL. 17; NO 12; PP. 919-926; ABS. ANGL. RUSSE ALLEM.; BIBL. 16 REF.Serial Issue

NAPROXEN. A NOVEL APPROACH TO DOSE-FINDING EFFICACY TRIALS IN RHEUMATOID ARTHRITIS = LE NAPROXEN: UNE NOUVELLE APPROCHE DES ESSAIS D'EFFICACITE POUR TROUVER LA DOSE DANS L'ARTHRITE RHUMATOIDELUSSIER A; SEGRE E; MULTZ CV et al.1973; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1973; VOL. 14; NO 3; PP. 434-441; BIBL. 14REF.Serial Issue

Simple fluorometric ultramicroassay for urea in tubular fluid of the kidneyLENG, L; SZANYIOVA, M; FAIX, S et al.Pflügers Archiv. 1986, Vol 406, Num 6, pp 648-650, issn 0031-6768Article

The use of a ⁵¹Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugsLUSSIER, A; ARSENAULT, A; VARADY, J et al.Seminars in arthritis and rheumatism. 1988, Vol 17, Num 3, pp 40-45, issn 0049-0172, suppl. 2 1Article

Effects of alprostadil and prazosin on motility, viability and membrane integrity of human spermHELLSTROM, W. J. G; WANG, R; PETERSON, C. A et al.The Journal of urology. 1998, Vol 159, Num 5, pp 1559-1562, issn 0022-5347Article

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadilHELLSTROM, W. J. G; BENNETT, A. H; PLACE, V. A et al.Urology (Ridgewood, NJ). 1996, Vol 48, Num 6, pp 851-856, issn 0090-4295Article